Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease
Eligible age
All ages
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this observational cross-sectional study is to explore the characteristics of language, speech, and motor function in persons with Mild Cognitive Impairment due to Alzheimer's disease ("MCI due to AD") and persons with mild and moderate Alzheimer's disease ("AD"). This study aims to: * Explore motor, speech, and language functions in MCI due to AD and mild and moderate AD. * Combine the characteristics of motor, language, and speech functions to gain more insight into the association of language, speech, and motor changes during MCI due to AD and mild and moderate AD. Researchers will compare the outcomes to an age-matched control group without cognitive impairment. Participants will undergo: * Two motor function tests to assess gait and hand grip strength. * Four language and speech function tests to assess spontaneous speech and verbal fluency..
Sponsor: Hanze University of Applied Sciences Groningen
You may qualify if…
- ✓ A subject with MCI with a likelihood of underlying AD pathophysiology must meet the following criteria:
- ✓ Established diagnosis of MCI due to AD with a likelihood according to NIA-AA criteria (Albert et al., 2011).
- ✓ A score of stage three on the Global Deterioration Scale (GDS) (Reisberg et al., 1982).
- ✓ A subject with AD must meet the following criteria:
- ✓ Established diagnosis of AD (amnestic or non-amnestic) or etiologically mixed presentation of AD according to DSM-5 (American Psychiatric Association, 2013) or NINCDS-ARDRA criteria (Jack et al., 2018; McKann et al., 2011).
- ✓ The following scores on the Global Deterioration Scale (GDS): four for mild AD, five for moderate AD (Reisberg et al., 1982).
- ✓ All subjects of the control group must meet the following criteria:
- ✓ A score of stage one or two on the Global Deterioration Scale (GDS) (Reisberg et al., 1982).
You may not qualify if…
- ✕ A subject with MCI due to AD or AD who meets the following criteria will be excluded from participation in this study:
- ✕ Having a neurological or neurodegenerative disease or disorder that may be contributing to cognitive impairment above and beyond that caused by AD or mixed AD; Down's syndrome, other subtypes of dementia, autism spectrum disorder.
- ✕ Having an established diagnosis of a psychiatric disorder, e.g. schizophrenia, depression.
- ✕ All subjects in the control group who meets following criteria will be excluded from participation in this study:
- ✕ ● Suffers from a neurological, neurodegenerative or psychiatric disease or disorder.
- ✕ All subjects in any group who meet any of the following criteria will be excluded from participation in this study:
- ✕ Hearing loss (with or without hearing aid) that affects communication.
- ✕ Vision loss (with or without glasses or lenses) that affects communication.
Source: ClinicalTrials.gov · NCT06508268 · last updated 2024-07-18